Alexandria Real Estate Equities, Inc.

What they do

Alexandria owns and operates Class A/A+ life science properties clustered in Megacampus ecosystems in Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2026, it had 36.0 million RSF of operating properties and 2.8 million RSF of Class A/A+ properties under construction, with tenants including pharmaceutical, biotechnology, life science product, advanced technology, academic, and government research organizations. It also provides strategic capital to life science companies through a venture capital platform.

Revenue drivers

• Rental revenue from operating properties — The primary revenue source is base rent from leased life science and technology space. Approximately 91% of leases (on an annual rental revenue basis) are triple net and approximately 97% contain effective annual rent escalations of about 3%.
• Megacampus platform — The Megacampus platform generated 80% of total annual rental revenue in effect as of the second quarter of 2026, reflecting concentration in collaborative cluster locations.
• Investment-grade and large cap tenant base — Investment-grade or publicly traded large cap tenants represented 57% of annual rental revenue as of June 30, 2026, supporting rent stability.
• Venture capital platform — Alexandria provides strategic capital to transformative life science companies through its venture capital platform; no revenue contribution is quantified in the provided excerpts.

Recent performance

For the second quarter of 2026, net loss attributable to Alexandria's common stockholders was $73.7 million, or $0.43 per diluted share, compared to a net loss of $109.6 million, or $0.64 per share, in the second quarter of 2025. For the six months ended June 30, 2026, net income attributable to common stockholders was $286.7 million, or $1.68 per diluted share, compared to a net loss of $121.2 million, or $0.71 per share, in the prior-year period. Funds from operations, as adjusted, were $296.1 million, or $1.73 per share, for the second quarter of 2026, down from $396.4 million, or $2.33 per share, in the second quarter of 2025. Total revenue for the second quarter of 2026 was $662.8 million, down from $754.4 million in the fourth quarter of 2025. Occupancy of operating properties was 86.9% as of June 30, 2026, or 90.9% including executed leases with future occupancy.

Strategy

Alexandria focuses on Class A/A+ properties in collaborative Megacampus ecosystems located near top academic and medical research institutions and transit. The company designs these ecosystems for optionality and scalability to support tenant growth through future developments and redevelopments. It seeks to retain existing tenants and attract new leading tenants by leveraging long-standing real estate and life science industry relationships. On December 3, 2025, the Board declared a fourth-quarter 2025 dividend of $0.72 per common share, a 45% reduction from the prior quarter, and noted it may reduce or suspend dividends in the future. The company continues to develop and redevelop properties, with 2.8 million RSF under construction as of June 30, 2026.

Risks

• Dividend reduction and distribution risk — The Board reduced the quarterly dividend by 45% in the fourth quarter of 2025 and may reduce or suspend dividends further, which could negatively impact the stock price.
• Tenant credit and rent collection risk — The company's tenants include public and private biotechnology companies, which may be unable to pay rent, and investment-grade or large cap tenants represented only 57% of annual rental revenue as of June 30, 2026.
• Development and acquisition risk — Alexandria may be unable to identify and complete acquisitions, investments, or development or redevelopment projects, or to successfully and profitably operate properties.
• International operations risk — The company has a small portfolio of operating properties in Canada, exposing it to foreign exchange, repatriation, regulatory, and tax risks.

Outlook

The provided excerpts do not include specific forward guidance figures. Management reported second-quarter 2026 results and highlighted the Megacampus platform, tenant quality, and lease structure, but the earnings release excerpt does not state explicit future financial targets. The company noted that the Board may reduce or suspend dividends in the future.